DarioHealth annual operating margin
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
DarioHealth's operating margin was −163.94% for fiscal 2025.
View full DarioHealth company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −163.94% | +49.61 pp |
| 2024 | 2024-12-31 | −213.55% | +62.54 pp |
| 2023 | 2023-12-31 | −276.09% | −70.67 pp |
| 2022 | 2022-12-31 | −205.42% | +167.49 pp |
| 2021 | 2021-12-31 | −372.90% | +21.80 pp |
| 2020 | 2020-12-31 | −394.71% | −160.48 pp |
| 2019 | 2019-12-31 | −234.22% | +5.00 pp |
| 2018 | 2018-12-31 | −239.22% | +39.68 pp |
| 2017 | 2017-12-31 | −278.90% | +117.14 pp |
| 2016 | 2016-12-31 | −396.04% | +539.32 pp |
| 2015 | 2015-12-31 | −935.36% | +21335.23 pp |
| 2014 | 2014-12-31 | −22,270.59% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −125.15% | +46.20 pp |
| Q1 2026 | 2026-03-31 | −130.89% | +8.46 pp |
| Q4 2025 | 2025-12-31 | −163.68% | −10.23 pp |
| Q3 2025 | 2025-09-30 | −189.41% | −27.35 pp |
| Q2 2025 | 2025-06-30 | −171.35% | +87.49 pp |
| Q1 2025 | 2025-03-31 | −139.35% | +170.74 pp |
| Q4 2024 | 2024-12-31 | −153.45% | +239.67 pp |
| Q3 2024 | 2024-09-30 | −162.06% | +279.83 pp |
| Q2 2024 | 2024-06-30 | −258.85% | −30.96 pp |
| Q1 2024 | 2024-03-31 | −310.09% | −134.49 pp |
| Q4 2023 | 2023-12-31 | −393.11% | −260.79 pp |
| Q3 2023 | 2023-09-30 | −441.90% | −221.26 pp |
| Q2 2023 | 2023-06-30 | −227.89% | +52.80 pp |
| Q1 2023 | 2023-03-31 | −175.60% | +21.35 pp |
| Q4 2022 | 2022-12-31 | −132.32% | +227.08 pp |
| Q3 2022 | 2022-09-30 | −220.64% | +179.06 pp |
| Q2 2022 | 2022-06-30 | −280.69% | +61.51 pp |
| Q1 2022 | 2022-03-31 | −196.95% | +201.58 pp |
| Q4 2021 | 2021-12-31 | −359.41% | +76.36 pp |
| Q3 2021 | 2021-09-30 | −399.70% | −76.39 pp |
| Q2 2021 | 2021-06-30 | −342.20% | −111.48 pp |
| Q1 2021 | 2021-03-31 | −398.53% | +208.19 pp |
| Q4 2020 | 2020-12-31 | −435.77% | −203.23 pp |
| Q3 2020 | 2020-09-30 | −323.31% | −173.47 pp |
| Q2 2020 | 2020-06-30 | −230.72% | +94.05 pp |
| Q1 2020 | 2020-03-31 | −606.72% | −367.51 pp |
| Q4 2019 | 2019-12-31 | −232.54% | +57.23 pp |
| Q3 2019 | 2019-09-30 | −149.84% | +65.91 pp |
| Q2 2019 | 2019-06-30 | −324.77% | −43.42 pp |
| Q1 2019 | 2019-03-31 | −239.21% | −73.20 pp |
| Q4 2018 | 2018-12-31 | −289.76% | −92.24 pp |
| Q3 2018 | 2018-09-30 | −215.75% | +0.90 pp |
| Q2 2018 | 2018-06-30 | −281.35% | +58.98 pp |
| Q1 2018 | 2018-03-31 | −166.00% | +251.57 pp |
| Q4 2017 | 2017-12-31 | −197.53% | +259.99 pp |
| Q3 2017 | 2017-09-30 | −216.65% | +157.11 pp |
| Q2 2017 | 2017-06-30 | −340.33% | +51.75 pp |
| Q1 2017 | 2017-03-31 | −417.58% | −79.02 pp |
| Q4 2016 | 2016-12-31 | −457.52% | +147.03 pp |
| Q3 2016 | 2016-09-30 | −373.76% | +559.20 pp |
| Q2 2016 | 2016-06-30 | −392.08% | +471.92 pp |
| Q1 2016 | 2016-03-31 | −338.56% | +2313.68 pp |
| Q4 2015 | 2015-12-31 | −604.55% | +4454.28 pp |
| Q3 2015 | 2015-09-30 | −932.97% | — |
| Q2 2015 | 2015-06-30 | −864.00% | — |
| Q1 2015 | 2015-03-31 | −2,652.24% | — |
| Q4 2014 | 2014-12-31 | −5,058.82% | — |
Over the last five reported fiscal years, DarioHealth's operating margin increased from −394.71% to −163.94%, a change of +230.77 percentage points. The latest reported quarter, Q2 2026, shows −125.15%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review DarioHealth filings at SEC.gov ↗